|
1
|
Laslett LJ, Alagona P Jr, Clark BA III,
Drozda JP Jr, Saldivar F, Wilson SR, Poe C and Hart M: The
worldwide environment of cardiovascular disease: Prevalence,
diagnosis, therapy, and policy issues: A report from the American
college of cardiology. J Am Coll Cardiol. 60(25 Suppl): S1–S49.
2012. View Article : Google Scholar
|
|
2
|
Homburg PJ, Rozie S, van Gils MJ, Jansen
T, de Weert TT, Dippel DW and van der Lugt A: Atherosclerotic
plaque ulceration in the symptomatic internal carotid artery is
associated with nonlacunar ischemic stroke. Stroke. 41:1151–1156.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lusis AJ: Atherosclerosis. Nature.
407:233–241. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chong H, Wei Z, Namuhan, Sun G, Zheng S,
Zhu X, Xue Y, Zhou Q, Guo S, Xu J, et al: The PGC-1α/NRF1/miR-378a
axis protects vascular smooth muscle cells from FFA-induced
proliferation, migration and inflammation in atherosclerosis.
Atherosclerosis. 297:136–145. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang M, Li F, Wang X, Gong J, Xian Y,
Wang G, Zheng Z, Shang C, Wang B, He Y, et al: MiR-145 alleviates
Hcy-induced VSMC proliferation, migration, and phenotypic switch
through repression of the PI3K/Akt/mTOR pathway. Histochem Cell
Biol. March 2–2020.Epub ahead of print.
|
|
6
|
Wang Q, Li DC, Li ZF, Liu CX, Xiao YM,
Zhang B, Li XD, Zhao J, Chen LP, Xing XM, et al: Upregulation of
miR-27a contributes to the malignant transformation of human
bronchial epithelial cells induced by SV40 small T antigen.
Oncogene. 30:3875–3886. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang P, Xu TY, Guan YF, Zhao Y, Li ZY, Lan
XH, Wang X, Yang PY, Kang ZM, Vanhoutte PM and Miao CY: Vascular
smooth muscle cell apoptosis is an early trigger for hypothyroid
atherosclerosis. Cardiovasc Res. 102:448–459. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Grootaert MOJ, Moulis M, Roth L, Martinet
W, Vindis C, Bennett MR and De Meyer GRY: Vascular smooth muscle
cell death, autophagy and senescence in atherosclerosis. Cardiovasc
Res. 114:622–634. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pirillo A, Norata GD and Catapano AL:
LOX-1, OxLDL, and atherosclerosis. Mediators Inflamm.
2013:1527862013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen X, Yan CC, Zhang X and You ZH: Long
non-coding RNAs and complex diseases: From experimental results to
computational models. Brief Bioinform. 18:558–576. 2017.
|
|
11
|
Li H, Zhu H and Ge J: Long noncoding RNA:
Recent updates in atherosclerosis. Int J Biol Sci. 12:898–910.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu Y, Zheng L, Wang Q and Hu YW: Emerging
roles and mechanisms of long noncoding RNAs in atherosclerosis. Int
J Cardiol. 228:570–582. 2017. View Article : Google Scholar
|
|
13
|
Wu G, Cai J, Han Y, Chen J, Huang ZP, Chen
C, Cai Y, Huang H, Yang Y, Liu Y, et al: LincRNA-p21 regulates
neointima formation, vascular smooth muscle cell proliferation,
apoptosis, and atherosclerosis by enhancing p53 activity.
Circulation. 130:1452–1465. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shan K, Jiang Q, Wang XQ, Wang YN, Yang H,
Yao MD, Liu C, Li XM, Yao J, Liu B, et al: Role of long non-coding
RNA-RNCR3 in atherosclerosis-related vascular dysfunction. Cell
Death Dis. 7:e22482016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Luo X, He S, Hu Y, Liu J and Chen X:
Sp1-induced LncRNA CTBP1-AS2 is a novel regulator in cardiomyocyte
hypertrophy by interacting with FUS to stabilize TLR4. Cardiovasc
Pathol. 42:21–29. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Georges M, Coppieters W and Charlier C:
Polymorphic miRNA-mediated gene regulation: Contribution to
phenotypic variation and disease. Curr Opin Genet Dev. 17:166–176.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Giral H, Kratzer A and Landmesser U:
MicroRNAs in lipid metabolism and atherosclerosis. Best Pract Res
Clin Endocrinol Metab. 30:665–676. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
He JF, Luo YM, Wan XH and Jiang D:
Biogenesis of MiRNA-195 and its role in biogenesis, the cell cycle,
and apoptosis. J Biochem Mol Toxicol. 25:404–408. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Guo J, Wang M and Liu X: MicroRNA-195
suppresses tumor cell proliferation and metastasis by directly
targeting BCOX1 in prostate carcinoma. J Exp Clin Cancer Res.
34:912015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang Y, Zhang X, Zou C, Kung HF, Lin MC,
Dress A, Wardle F, Jiang BH and Lai L: MiR-195 inhibits tumor
growth and angiogenesis through modulating IRS1 in breast cancer.
Biomed Pharmacother. 80:95–101. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang M, Zhang J, Tong L, Ma X and Qiu X:
MiR-195 is a key negative regulator of hepatocellular carcinoma
metastasis by targeting FGF2 and VEGFA. Int J Clin Exp Pathol.
8:14110–14120. 2015.
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
23
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: A ceRNA hypothesis: The rosetta stone of a hidden RNA
language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang J, Ding W, Xu Y, Tao E, Mo M, Xu W,
Cai X, Chen X, Yuan J and Wu X: Long non-coding RNA RHPN1-AS1
promotes tumorigenesis and metastasis of ovarian cancer by acting
as a ceRNA against miR-596 and upregulating LETM1. Aging (Albany
NY). 12:4558–4572. 2020. View Article : Google Scholar
|
|
25
|
Zhao D, Zhang H, Long J and Li M: LncRNA
SNHG7 functions as an oncogene in cervical cancer by sponging
miR-485-5p to modulate JUND expression. Onco Targets Ther.
13:1677–1689. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Weber C and Noels H: Atherosclerosis:
Current pathogenesis and therapeutic options. Nat Med.
17:1410–1422. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang Z, Salisbury D and Sallam T: Long
noncoding RNAs in atherosclerosis: JACC review topic of the week. J
Am Coll Cardiol. 72:2380–2390. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhou T, Ding JW, Wang XA and Zheng XX:
Long noncoding RNAs and atherosclerosis. Atherosclerosis.
248:51–61. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang K, Sun Y, Tao W, Fei X and Chang C:
Androgen receptor (AR) promotes clear cell renal cell carcinoma
(ccRCC) migration and invasion via altering the
circHIAT1/miR-195-5p/29a-3p/29c-3p/CDC42 signals. Cancer Lett.
394:1–12. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Qu Q, Chu X and Wang P: MicroRNA-195-5p
suppresses osteosarcoma cell proliferation and invasion by
suppressing naked cuticle homolog 1. Cell Biol Int. 41:287–295.
2017. View Article : Google Scholar
|
|
31
|
Wang YS, Wang HY, Liao YC, Tsai PC, Chen
KC, Cheng HY, Lin RT and Juo SH: MicroRNA-195 regulates vascular
smooth muscle cell phenotype and prevents neointimal formation.
Cardiovasc Res. 95:517–526. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Nakajima K, Nakano T and Tanaka A: The
oxidative modification hypothesis of atherosclerosis: The
comparison of atherogenic effects on oxidized LDL and remnant
lipoproteins in plasma. Clin Chim Acta. 367:36–47. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chistiakov DA, Orekhov AN and Bobryshev
YV: Vascular smooth muscle cell in atherosclerosis. Acta Physiol
(Oxf). 214:33–50. 2015. View Article : Google Scholar
|
|
34
|
Johnson JL: Emerging regulators of
vascular smooth muscle cell function in the development and
progression of atherosclerosis. Cardiovasc Res. 103:452–460. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cheng Y, Wang B, Zhou H, Dang S, Jin M,
Shi Y, Hao L, Yang Z and Zhang Y: Autophagy is required for the
maintenance of liver progenitor cell functionality. Cell Physiol
Biochem. 36:1163–1174. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
De Meyer GR, Grootaert MO, Michiels CF,
Kurdi A, Schrijvers DM and Martinet W: Autophagy in vascular
disease. Circ Res. 116:468–479. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li BH, Yin YW, Liu Y, Pi Y, Guo L, Cao XJ,
Gao CY, Zhang LL and Li JC: TRPV1 activation impedes foam cell
formation by inducing autophagy in oxLDL-treated vascular smooth
muscle cells. Cell Death Dis. 5:e11822014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
He K, Sun H, Zhang J, Zheng R, Gu J, Luo M
and Shao Y: Rab7mediated autophagy regulates phenotypic
transformation and behavior of smooth muscle cells via the
Ras/Raf/MEK/ERK signaling pathway in human aortic dissection. Mol
Med Rep. 19:3105–3113. 2019.PubMed/NCBI
|
|
39
|
Bennett MR, Sinha S and Owens GK: Vascular
smooth muscle cells in atherosclerosis. Circ Res. 118:692–702.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hassanpour M, Rahbarghazi R, Nouri M,
Aghamohammadzadeh N, Safaei N and Ahmadi M: Role of autophagy in
atherosclerosis: Foe or friend? J Inflamm (Lond). 16:82019.
View Article : Google Scholar
|
|
41
|
Sun Q, Fan W, Chen K, Ding X, Chen S and
Zhong Q: Identification of barkor as a mammalian autophagy-specific
factor for Beclin 1 and class III phosphatidylinositol 3-kinase.
Proc Natl Acad Sci USA. 105:19211–19216. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Martinet W and De Meyer GR: Autophagy in
atherosclerosis: A cell survival and death phenomenon with
therapeutic potential. Circ Res. 104:304–317. 2009. View Article : Google Scholar : PubMed/NCBI
|
